https://www.Heart-Valve-Surgery.com - As new minimally-invasive devices for the treatment of aortic valve disease transform heart valve therapy, patients with bicuspid aortic valves are asking important questions about the optimal use of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) techniques given their congenital, two-cusp valves.
For that reason, we interviewed Dr. Christopher Mehta, a leading cardiac surgeon at Northwestern Medicine in Chicago, Illinois. Dr. Mehta specializes in the treatment of bicuspid aortic valves, aortic stenosis, aortic regurgitation and aortic aneurysms.
Key questions asked-and-answered in this video include:
1. What is a bicuspid aortic valve (BAV)? Prevalence? Symptoms? Causes? Risks?
2. How does Northwestern Medicine manage patients with BAV?
3. When is treatment needed for bicuspid aortic valve patients?
4. What are the treatment options? SAVR? TAVR?
5. What criteria does Dr. Mehta and the patient consider for evaluating a SAVR vs. TAVR treatment option?
6. Specific to BAV patients…What are outcomes for both SAVR? TAVR?
7. Have there been clinical trials for BAV patients specific to TAVR? Why of why not?
8. What is Dr. Mehta's #1 piece of advice for BAV patients needing treatment?
To learn more or schedule an appointment with Dr. Mehta, please call (888) 515-0285 or visit https://www.heart-valve-surgery.com/surgeons/dr-Christopher-Mehta-Chicago-Illinois.php.
